(Q40379085)

English

Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands (English)

1 reference

Europe PubMed Central

20 September 2017

1 reference

based on heuristic

inferred from title

author name string

Aldrich WA

1

1 reference

Europe PubMed Central

20 September 2017

Ren C

2

1 reference

Europe PubMed Central

20 September 2017

White AF

3

1 reference

Europe PubMed Central

20 September 2017

Zhou SZ

4

1 reference

Europe PubMed Central

20 September 2017

Kumar S

5

1 reference

Europe PubMed Central

20 September 2017

Jenkins CB

6

1 reference

Europe PubMed Central

20 September 2017

Shaw DR

7

1 reference

Europe PubMed Central

20 September 2017

Strong TV

8

1 reference

Europe PubMed Central

20 September 2017

Triozzi PL

9

1 reference

Europe PubMed Central

20 September 2017

Ponnazhagan S

10

1 reference

Europe PubMed Central

20 September 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

13

1 reference

Europe PubMed Central

20 September 2017

1

1 reference

Europe PubMed Central

20 September 2017

29-39

1 reference

Europe PubMed Central

20 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302601

0 references

Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Immune responses to recombinant adeno-associated virus vectors: putting preclinical findings into perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Adenoassociated virus vectors for genetic immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvant.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Dendritic cell immunotherapy: mapping the way.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Gene transfer into skeletal muscle using novel AAV serotypes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Id proteins negatively regulate basic helix-loop-helix transcription factor function by disrupting subnuclear compartmentalization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Dendritic cells: specialized and regulated antigen processing machines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Exploiting dendritic cells to improve vaccine efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Rate limiting steps of AAV transduction and implications for human gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

21 January 2018

Adeno-associated virus vectors for therapeutic gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

7 January 2021

based on heuristic

inferred from DOI database lookup

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302601

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3302601

1 reference

Europe PubMed Central

20 September 2017

Dimensions Publication ID

0 references

release_7w5gmmys5vcqjcwuwamgk2s7d4

1 reference

https://api.fatcat.wiki/v0/release/7w5gmmys5vcqjcwuwamgk2s7d4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40379085&oldid=1896470258"